Project Grant HT94252510236

Award Date 5/15/25
Completion Date 5/14/29
Dollars Obligated $3.2M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
This $2,728,777 Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports advanced biomedical research on neuroactive steroid biosynthesis and dynamic GABAA receptor reconfiguration in postpartum depression. The award was granted to the Rector & Visitors of the University of Virginia, a public research university in Charlottesville, Virginia, for the project period from May 1, 2025 to April 30,...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
This $1,195,956 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and translation of a virtual reality-based military operational neuropsychological assessment tool. The funding will enable the University of Arizona, as the prime awardee, to create and validate a model for this innovative virtual reality assessment system. The anticipated completion date for this 3-year effort is September 29,...
This federal Project Grant award, valued at $153,309.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of Massachusetts to model the spread of airborne pathogens through lung-on-a-chip technology. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, and treatment. The...
This $5,540,949 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the University of Virginia's research on focused ultrasound interventions for non-invasive precision therapy in primary and metastatic breast cancers. The five-year award, running from September 2025 to September 2029, will fund innovative biomedical research to advance cancer treatment methods, with a focus on transforming...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The...
This federal Project Grant award in the amount of $2,013,978.00 was provided by the Defense Health Agency, which administers the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The award was granted to New York University (NYU) School of Medicine, a prominent academic medical center and research institution, to conduct research on...
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...

This federal Project Grant award, with an obligated amount of $3,208,546.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award aims to support the expansion of the Generalized Blast Exposure Value Tool to determine cumulative blast exposure thresholds in military populations. The University of Virginia, a non-profit research university, will serve as the prime awardee for this 4-year project, which commenced on May 15, 2025 and is scheduled to be completed by May 14, 2029. The project focuses on advancing research and development in the area of blast exposure analysis and medical treatment for military service members, leveraging the university's expertise in specialized scientific domains.

Generated 6/17/25, 5:39 AM